Development of Calm for Cancer Prototype Mobile App

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

March 15, 2022

Conditions
Cancer
Interventions
OTHER

Calm Meditation Smartphone App Feedback

Advisory committee members will be asked to use the current Calm meditation app platform for a full week and to keep an informal journal prior to participating in focus groups in which they will provide feedback about the app.

OTHER

Cancer-Specific Meditation App Prototype Design

Findings from Aim 1 will inform the development of a cancer-specific meditation app prototype to be tested in Aim 3.

DEVICE

Cancer-Specific Meditation App Prototype

Recruited cancer patients/survivors will be asked to beta-test the cancer-specific app prototype for four weeks. The prototype will be developed in Aim 2 and informed by qualitative findings of Aim 1.

Trial Locations (1)

94108

Calm, Inc., San Francisco

All Listed Sponsors
collaborator

The University of Texas Health Science Center at San Antonio

OTHER

collaborator

Arizona State University

OTHER

lead

Calm.com, Inc.

INDUSTRY

NCT05459168 - Development of Calm for Cancer Prototype Mobile App | Biotech Hunter | Biotech Hunter